The Sheffield Teaching Hospitals NHS Foundation Trust is an NHS Foundation Trust located in Sheffield, England.

During the past decade, Sheffield Teaching Hospitals NHS Foundation Trust conducted 180 clinical trials. In the 10-year time frame, 180 clinical trials started and 29 clinical trials were completed, i.e. on average, 16.1% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 21 clinical trials were completed. i.e. 27.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sheffield Teaching Hospitals NHS Foundation Trust" #1 sponsor was "Sheffield Teaching Hospitals NHS Foundation Trust" with 85 trials, followed by "University College, London" with 11 trials sponsored, "Actelion" with 10 trials sponsored, "Celgene" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 88 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sheffield Teaching Hospitals NHS Foundation Trust" #1 collaborator was "University of Sheffield" with 25 trials as a collaborator, "Sheffield Teaching Hospitals NHS Foundation Trust" with 12 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 9 trials as a collaborator, "Sheffield Hallam University" with 6 trials as a collaborator and "Cambridge University Hospitals NHS Foundation Trust" with 5 trials as a collaborator. Other collaborators include 252 different institutions and companies that were collaborators in the rest 203 trials.

According to Clinical.Site data, the most researched conditions in "Sheffield Teaching Hospitals NHS Foundation Trust" are "Multiple Sclerosis" (7 trials), "Coronary Artery Disease" (6 trials), "Multiple Myeloma" (6 trials), "Prostate Cancer" (5 trials) and "Acute Coronary Syndrome" (4 trials). Many other conditions were trialed in "Sheffield Teaching Hospitals NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Sheffield Teaching Hospitals NHS Foundation Trust" are "Drug" (88 trials), "Other" (46 trials), "Procedure" (30 trials), "Device" (26 trials) and "Diagnostic Test" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Macitentan" (4 trials), "Standard of Care" (4 trials), "Alemtuzumab" (2 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sheffield Teaching Hospitals NHS Foundation Trust" are 208 trials for "All" genders, 12 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Sheffield Teaching Hospitals NHS Foundation Trust". 1 are not yet recruiting, 44 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in Sheffield Teaching Hospitals NHS Foundation Trust, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Sheffield Teaching Hospitals NHS Foundation Trust, 9 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 74 trials that are defined as “Not Applicable".

Sheffield Teaching Hospitals NHS Foundation Trust has several departments that took part in Clinical trials: "Weston Park Hospital; Cancer Clinical Trials Centre" - 10 trials, "Sheffield Vascular Institute, Sheffield Teaching Hospitals NHS - Northern General" - 2 trials, "Sheffield Kidney Unit, Northern General Hospital" - 2 trials